WallStSmart
MTVA

MetaVia Inc.

NASDAQ: MTVA · HEALTHCARE · BIOTECHNOLOGY

$1.41
+5.22% today

Updated 2026-10-09

Market cap
$10.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.45
Dividend yield
—
52W range
$1 – $15
Volume
0.1M

MetaVia Inc. (MTVA) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
-195.10%
ROA
-58.80%
Debt/equity
0.03x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2014—$-320000.00———
2015—$-9.03M———
2016—$-14.59M———
2017—$-33.41M———
2018—$-15.53M———
2019—$-21.31M———
2020$0.00$-29.68M———
2021$0.00$-15.28M———
2022$0.00$-13.97M———
2023$0.00$-12.47M———
2024$0.00$-27.59M———
2025$0.00$-12.97M———

Frequently asked questions

How much free cash flow does MTVA generate?

MTVA produced $-15.70M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is MTVA's balance sheet healthy?

MTVA holds $10.28M in cash and equivalents against — in long-term debt, on $5.33M of shareholder equity. That debt is best read against the cash flow the business throws off each year.